Skip to main content
SpringerLink
Log in

Immunodeficiency Disorders

  • Chapter
Therapy of Skin Diseases

  • 1460 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Agostoni A, Aygoren-Pursun E, Binkley KE et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51–S131

    Article  PubMed  Google Scholar 

  2. Bauer TR, Schwartz BR, Liles WC et al (1998) Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91:1520–1526

    PubMed  CAS  Google Scholar 

  3. Bracho FA (2005) Hereditary angioedema. Curr Opin Hematol 12:493–498

    Article  PubMed  Google Scholar 

  4. Buckley RH (2004) The multiple causes of human SCID. J Clin Invest 114:1409–1411

    PubMed  CAS  Google Scholar 

  5. Buoni S, Zannolli R, Sorrentino L et al (2006) Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia. Arch Neurol 63:1479–1482

    Article  PubMed  Google Scholar 

  6. Collins SM, Dominguez M, Ilmarinen T et al (2006) Dermatological manifestations of autoimmune polyendo-crinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093

    Article  PubMed  CAS  Google Scholar 

  7. Conley ME, Saragoussi D, Notarangelo L et al (2003) An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 109:272–277

    Article  PubMed  CAS  Google Scholar 

  8. DeWitt CA, Bishop AB, Buescher LS et al (2006) Hyperimmunoglobulin E syndrome: two cases and a review of the literature. J Am Acad Dermatol 54:855–865

    Article  PubMed  Google Scholar 

  9. Dupre L, Marangoni F, Scaramuzza S et al (2006) Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WA S promoter/cDNA-containing lentiviral vector and nonlethal irradiation. Hum Gene Ther 17:303–313

    Article  PubMed  CAS  Google Scholar 

  10. Eapen M, Delaat CA, Baker KS et al (2007) Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 39:411–415

    Article  PubMed  CAS  Google Scholar 

  11. Eberting CL, Davis J, Puck JM et al (2004) Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol 140:1119–1125

    Article  PubMed  Google Scholar 

  12. Gallin JI, Alling DW, Malech HL et al (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348:2416–2422

    Article  PubMed  CAS  Google Scholar 

  13. Grimbacher B, Holland SM, Puck JM (2005) Hyper-IgE syndromes. Immunol Rev 203:244–250

    Article  PubMed  CAS  Google Scholar 

  14. Gungor T, Halter J, Klink A et al (2005) Successful low tox-icity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 79:1596–1606

    Article  PubMed  Google Scholar 

  15. Jayasinghe M, Schmidt S, Walker B et al (2006) Successful treatment of azole-resistant chronic mucocutaneous candi-dosis with caspofungin. Acta Derm Venereol 86:563–564

    Article  PubMed  Google Scholar 

  16. Lai CH, Chun HH, Nahas SA et al (2004) Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc Natl Acad Sci U S A 101:15676–15681

    Article  PubMed  CAS  Google Scholar 

  17. Malech HL, Hickstein DD (2007) Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol 14:29–36

    Article  PubMed  Google Scholar 

  18. Marciano BE, Wesley R, De Carlo ES et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39:692–699

    Article  PubMed  CAS  Google Scholar 

  19. Namazi MR, Handjani F (2006) Lithium: a potential treatment for hyper-IgE syndrome. Med Hypotheses 66:1047

    Article  PubMed  CAS  Google Scholar 

  20. Orange JS, Levy O, Geha RS (2005) Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 203:21–37

    Article  PubMed  CAS  Google Scholar 

  21. Orange JS, Stone KD, Turvey SE et al (2004) The Wiskott-Aldrich syndrome. Cell Mol Life Sci 61:2361–2385

    Article  PubMed  CAS  Google Scholar 

  22. Peces R (2002) Partial lipodystrophy in two HLA identical sisters with hypocomplementemia and nephropathy. Nefrologia 22:564–569

    PubMed  CAS  Google Scholar 

  23. Polizzi B, Origgi L, Zuccaro G et al (1996) Case report: successful treatment with cimetidine and zinc sulphate in chronic mucocutaneous candidiasis. Am J Med Sci 311: 189–190

    Article  PubMed  CAS  Google Scholar 

  24. Puck JM, Malech HL (2006) Gene therapy for immune disorders: good news tempered by bad news. J Allergy Clin Immunol 117:865–869

    Article  PubMed  CAS  Google Scholar 

  25. Puel A, Picard C, Ku CL et al (2004) Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol 16:34–41

    Article  PubMed  CAS  Google Scholar 

  26. Reeves EP, Lu H, Jacobs HL et al (2002) Killing activity of neutrophils is mediated through activation of proteases by K + flux. Nature 416:291–297

    Article  PubMed  CAS  Google Scholar 

  27. Ridanpaa M, van Eenennaam H, Pelin K et al (2001) Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104:195–203

    Article  PubMed  CAS  Google Scholar 

  28. Rosenzweig SD, Holland SM (2004) Phagocyte immunode-ficiencies and their infections. J Allergy Clin Immunol 113:620–626

    Article  PubMed  CAS  Google Scholar 

  29. Sanal O, Gocmen A, Tezcan I et al (1990) Hyper-IgE syndrome: a case report. Turk J Pediatr 32:273–278

    PubMed  CAS  Google Scholar 

  30. Sastry J, Kakakios A, Tugwell H et al (2006) Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatr Blood Cancer 47: 327–329

    Article  PubMed  Google Scholar 

  31. Schurman SH, Candotti F (2003) Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 15:446–453

    Article  PubMed  CAS  Google Scholar 

  32. Shackelford RE, Manuszak RP, Johnson CD et al (2004) Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress. DNA Repair (Amst) 3: 1263–1272

    Article  CAS  Google Scholar 

  33. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155–168

    Article  PubMed  CAS  Google Scholar 

  34. Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59

    Article  PubMed  CAS  Google Scholar 

  35. Suzuki T, Imamura A (2005) A case of chronic mucocutane-ous candidasis cured with micafungin. Kansenshogaku Zasshi 79:143–148

    PubMed  Google Scholar 

  36. Wang J, Cunningham-Rundles C (2005) Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 25: 57–62

    Article  PubMed  CAS  Google Scholar 

  37. Weiler CR, Bankers-Fulbright JL (2005) Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 80:1187–1200

    Article  PubMed  CAS  Google Scholar 

  38. Winkelstein JA, Marino MC, Ochs H et al (2003) The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82: 373–384

    Article  CAS  Google Scholar 

  39. Wolach B, Eliakim A, Pomeranz A et al (1996) Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet 347:67

    Article  PubMed  CAS  Google Scholar 

  40. Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D et al (2006) Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol 97:257–261

    Article  PubMed  CAS  Google Scholar 

  41. Zuraw BL (2005) Current and future therapy for hereditary angioedema. Clin Immunol 114:10–16

    Article  PubMed  CAS  Google Scholar 

  42. Zuraw BL (2006) Novel therapies for hereditary angioe-dema. Immunol Allergy Clin North Am 26:691–708

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Catania, Piazza S. Agata La Vetere 6, Catania, 95124, Italy

    Giuseppe Micali

  2. Department of Dermatology, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair Street, Suite 1600, Chicago, IL, 60611, USA

    Dennis P. West & Amy S. Paller

Authors
  1. Giuseppe Micali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dennis P. West
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amy S. Paller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Micali .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Köln Klinik und Poliklinik für Dermatologie und Venerologie, Kerpener Str. 62, Köln, 50924, Germany

    Thomas Krieg

  2. Dept. Dermatology, Columbia University Medical Center, 12th Floor, Herbert Irving Pavilion 161 Fort Washington Ave, New York, NY, 10032, USA

    David R. Bickers

  3. Dept. Dermatology & Cutaneous Sciences, Kyoto University Graduate School of Medicine, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Yoshiki Miyachi

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Micali, G., West, D.P., Paller, A.S. (2010). Immunodeficiency Disorders. In: Krieg, T., Bickers, D.R., Miyachi, Y. (eds) Therapy of Skin Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78814-0_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78814-0_51

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78813-3

  • Online ISBN: 978-3-540-78814-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation